As the world endures the coronavirus disease 2019 (COVID-19) pandemic, the conditions of 35 million vulnerable individuals struggling with substance use disorders (SUDs) worldwide have not received sufficient attention for their special health and medical needs Many of these individuals are complicated by underlying health conditions, such as cardiovascular and lung diseases and undermined immune systems During the pandemic, access to the healthcare systems and support groups is greatly diminished Current research on COVID-19 has not addressed the unique challenges facing individuals with SUDs, including the heightened vulnerability and susceptibility to the disease In this systematic review, we will discuss the pathogenesis and pathology of COVID-19, and highlight potential risk factors and complications to these individuals We will also provide insights and considerations for COVID-19 treatment and prevention in patients with SUDs
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications